|
TNPO3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7268099999912E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.5521999999959E-05 |
| Normal-vs-Stage2 |
1.314630E-01 |
| Normal-vs-Stage3 |
3.0884999999703E-06 |
| Normal-vs-Stage4 |
9.68469999973465E-07 |
| Stage1-vs-Stage2 |
8.627500E-02 |
| Stage1-vs-Stage3 |
1.317390E-01 |
| Stage1-vs-Stage4 |
4.913900E-02 |
| Stage2-vs-Stage3 |
1.376490E-02 |
| Stage2-vs-Stage4 |
9.197700E-03 |
| Stage3-vs-Stage4 |
6.568600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.16979999997824E-06 |
| Normal-vs-AfricanAmerican |
4.316400E-02 |
| Normal-vs-Asian |
2.201900E-02 |
| Caucasian-vs-AfricanAmerican |
2.540800E-01 |
| Caucasian-vs-Asian |
1.117790E-01 |
| AfricanAmerican-vs-Asian |
9.561400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.45129999999683E-05 |
| Normal-vs-Female |
3.58420000000637E-05 |
| Male-vs-Female |
4.763800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.971000E-04 |
| Normal-vs-Age(41-60Yrs) |
8.25110000000073E-05 |
| Normal-vs-Age(61-80Yrs) |
7.7390000000066E-05 |
| Normal-vs-Age(81-100Yrs) |
1.778510E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.908200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.748800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.950840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.473600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.851760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.065000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.424400E-02 |
| Classical-VS-Follicular |
5.441200E-01 |
| Classical-VS-Other |
4.812400E-01 |
| Classical-VS-Normal |
5.90029999999464E-05 |
| Tall-VS-Follicular |
3.128100E-02 |
| Tall-VS-Other |
8.267800E-01 |
| Tall-VS-Normal |
2.09019999999338E-05 |
| Follicular-VS-Other |
4.397200E-01 |
| Follicular-VS-Normal |
7.878400E-03 |
| Other-VS-Normal |
2.837900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.205500E-04 |
| Normal-vs-N1 |
1.31110000001211E-06 |
| N0-vs-N1 |
3.103500E-02 |
|
|
